Comparative study of two whole-body imaging techniques in the case of melanoma metastases: Advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT

European Journal of Radiology

Volumn 75, Issue 3, 2010, Pages 376-383

  Laurent, Valérie ^a   Trausch, Grégory ^b   Bruot, Olivier ^a   Olivier, Pierre ^a   Felblinger, Jacques ^c   Régent, Denis ^a  

^a CHU NANCY BRABOIS   (France)

^b GE HEALTHCARE   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Diffusion; Melanoma; MRI; Oncology; PET CT; Whole body

Indexed keywords

18-F-FLUORODEOXYGLUCOSE; COMPARATIVE STUDIES; MALIGNANT LESION; MELANOMA; MELANOMA METASTASIS; MRI; MRI (MAGNETIC RESONANCE IMAGING); PET-CT; SENSITIVITY AND SPECIFICITY; WHOLE-BODY; WHOLE-BODY IMAGING;

COMPUTERIZED TOMOGRAPHY; DERMATOLOGY; DIFFUSION; ONCOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RESONANCE; STANDARDS;

MAGNETIC RESONANCE IMAGING;

FLUCIS; FLUORODEOXYGLUCOSE F 18; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER METASTASIS; LYMPH NODE METASTASIS; MELANOMA; PERITONEUM METASTASIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SKIN METASTASIS; WHOLE BODY MRI;

CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MELANOMA; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956973903     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.04.059     Document Type: Article

References (25)

1. C.A. Cuenod, and J.P. Tasu Whole-body MRI J Radiol 80 1999 511 514
2. R. Walker, P. Kessar, and R. Blanchard Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience J Magn Reson Imaging 11 2000 343 350
3. R.E. Walker, and S.J. Eustace Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications Semin Musculoskelet Radiol 5 2001 5 20
4. M.M. Osman Whole-body imaging for cancer staging JAMA 291 2004 1320 [author reply 1320]
5. J.F. Schafer, A. Fischmann, and M. Lichy Oncologic screening with whole-body MRI: possibilities and limitations Radiology 44 2004 854 863
6. E.M. Charles-Edwards, and N.M. deSouza Diffusion-weighted magnetic resonance imaging and its application to cancer Cancer Imaging 6 2006 135 143
7. J. Barcelo, J.C. Vilanova, and E. Riera Diffusion-weighted whole-body MRI (virtual PET) in screening for osseous metastases Radiologia 49 2007 407 415
8. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 2007 1622 1635
9. S. Li, F. Sun, Z.Y. Jin, H.D. Xue, and M.L. Li Whole-body diffusion-weighted imaging: technical improvement and preliminary results J Magn Reson Imaging 26 2007 1139 1144
10. K. Nakanishi, M. Kobayashi, and K. Nakaguchi Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images Magn Reson Med Sci 6 2007 147 155
11. C. Muller-Horvat, P. Radny, and T.K. Eigentler Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma Eur J Cancer 42 2006 342 350
12. C. Pfannenberg, P. Aschoff, and S. Schanz Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma Eur J Cancer 43 2007 557 564
13. T.C. Lauenstein, L.S. Freudenberg, and S.C. Goehde Whole-body MRI using a rolling table platform for the detection of bone metastases Eur Radiol 12 2002 2091 2099
14. L. Blomqvist, and M.R. Torkzad Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology? JAMA 290 2003 3248 3249
15. G. Antoch, F.M. Vogt, A. Bockisch, and S.G. Ruehm Whole-body tumor staging: MRI or FDG-PET/CT? Radiology 44 2004 882 888
16. N. Ghanem, T. Kelly, and C. Altehoefer Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors Radiology 44 2004 864 873
17. T.C. Lauenstein, S.C. Goehde, and C.U. Herborn Whole-body MR imaging: evaluation of patients for metastases Radiology 233 2004 139 148
18. G.P. Schmidt, R. Schmid, K. Hahn, and M.F. Reiser Whole-body MRI and PET/CT in tumor diagnosis Radiology 44 2004 1079 1087
19. G. Antoch, F.M. Vogt, and L.S. Freudenberg Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology JAMA 290 2003 3199 3206
20. G.P. Schmidt, A. Baur-Melnyk, and P. Herzog High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system Invest Radiol 40 2005 743 753
21. M. Weininger, B. Lauterbach, and S. Knop Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns Eur J Radiol 69 2009 339 345
22. G.P. Schmidt, S.O. Schoenberg, and R. Schmid Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT Eur Radiol 17 2007 939 949
23. G.P. Schmidt, M.F. Reiser, and A. Baur-Melnyk Whole-body imaging of the musculoskeletal system: the value of MR imaging Skeletal Radiol 36 2007 1109 1119
24. V. Ribrag, D. Vanel, and S. Leboulleux Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy Eur J Radiol 66 2008 325 331
25. M.P. Lichy, P. Aschoff, and P. Plathow Tumor detection by diffusion-weighted MRI and ADC-mapping - initial clinical experiences in comparison to PET-CT Invest Radiol 42 2007 605 613